Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Verastem reported $97.26M in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
Alaunos Therapeutics Inc ZIOP:US USD 23.5M 15.56M
AstraZeneca AZN:LN USD 6.23B 66M
Curis CRIS:US USD 31.7M 12.04M
Cytokinetics CYTK:US USD 765.58M 700M
Gilead Sciences GILD:US USD 7.2B 430M
Immunogen IMGN:US USD 201.25M 73.89M
Incyte Corp INCY:US USD 2.82B 130.37M
Laboratory Of America LH:US USD 393.9M 36.1M
Novartis NOVN:VX USD 12B 4.48B
Roche Holding ROG:VX CHF 4.99B 676M
TG Therapeutics TGTX:US USD 61.47M 40.84M
Verastem VSTM:US USD 97.26M 22.33M